Novel is an enterprise NFT solution that enables NFTs to be integrated into a Shopify store, creating tokenized products, content, discounts, and more for NFT holders.
Odaily News The U.S. Securities and Exchange Commission (SEC) has published responses to its request for comments on "Novel ETFs," funds that may hold crypto assets or employ unconventional strategies. The divergence in opinions centers on whether filing documents should remain public before the fund begins trading, and how fast the review process should be.Crypto asset manager Grayscale and the crypto policy organization Crypto Council for Innovation (CCI) support an optional confidential filing period to reduce the likelihood of competitors submitting imitation filings. Charles Schwab opposes full confidentiality and suggests disclosing filings at least 75 days before a fund launches.Grayscale requests the SEC to respond within 45 days, while CCI argues that the confidential process should not extend the automatic effectiveness or review deadlines. Venture capital firm Andreessen Horowitz (A16z) supports shortening the review timeline but emphasizes that the rigor of the review should not be reduced. Trading firm Jane Street, however, contends that accelerating the process could lead to lower product quality, competitiveness, and liquidity.The U.S. currently has 174 ETFs related to crypto assets. BlackRock's iShares Bitcoin Trust ETF (IBIT) manages approximately $61 billion in assets, accounting for roughly 38% of the total assets of related ETFs. The SEC will determine whether adjustments will be made to the confidentiality arrangement and review speed of filings. (Bitcoin.com News)
the U.S. Securities and Exchange Commission (SEC) is seeking public comments on "novel ETFs" to evaluate its regulatory framework and market rule design. In the document, the SEC noted its ongoing attention to market interest in a variety of innovative products, including funds related to crypto assets, investment opportunities based on blockchain technology, and novel financial derivatives such as "event contracts."This request for comments is seen as a further proactive exploration by the SEC regarding the boundaries of ETF regulation. Particularly against the backdrop of sustained growth in demand for crypto ETFs, on-chain asset exposure products, and structured derivatives, regulators are attempting to find a new balance between innovation and risk control. (The Block)
Odaily News The U.S. Securities and Exchange Commission (SEC) has published responses to its request for comments on "Novel ETFs," funds that may hold crypto assets or employ unconventional strategies. The divergence in opinions centers on whether filing documents should remain public before the fund begins trading, and how fast the review process should be.Crypto asset manager Grayscale and the crypto policy organization Crypto Council for Innovation (CCI) support an optional confidential filing period to reduce the likelihood of competitors submitting imitation filings. Charles Schwab opposes full confidentiality and suggests disclosing filings at least 75 days before a fund launches.Grayscale requests the SEC to respond within 45 days, while CCI argues that the confidential process should not extend the automatic effectiveness or review deadlines. Venture capital firm Andreessen Horowitz (A16z) supports shortening the review timeline but emphasizes that the rigor of the review should not be reduced. Trading firm Jane Street, however, contends that accelerating the process could lead to lower product quality, competitiveness, and liquidity.The U.S. currently has 174 ETFs related to crypto assets. BlackRock's iShares Bitcoin Trust ETF (IBIT) manages approximately $61 billion in assets, accounting for roughly 38% of the total assets of related ETFs. The SEC will determine whether adjustments will be made to the confidentiality arrangement and review speed of filings. (Bitcoin.com News)
According to Bloomberg, Roche announced a collaboration with AI drug discovery company Recursion, betting on artificial intelligence technology to develop new drugs in the neuroscience field. This is one of the first attempts in the industry to adopt new AI methods to advance drug development. The background is that the neuroscience field has long faced the dilemma of unclear etiology—researchers still do not fully understand the pathogenesis of diseases such as Alzheimer's and Parkinson's, leading pharmaceutical companies to repeatedly target the same set of biological targets, with most attempts ending in failure. New-generation AI companies believe that leveraging AI technology holds promise to break through this bottleneck and significantly reduce drug trial failure rates.
According to Sifted, ETH Zurich spin-off startup ZuriQ announced the completion of a $25.5 million seed funding round. The company is dedicated to developing a new quantum chip architecture, which reportedly offers greater scalability compared to existing solutions and is expected to accelerate the scaling process in the field of quantum computing.
the U.S. Securities and Exchange Commission (SEC) is seeking public comments on "novel ETFs" to evaluate its regulatory framework and market rule design. In the document, the SEC noted its ongoing attention to market interest in a variety of innovative products, including funds related to crypto assets, investment opportunities based on blockchain technology, and novel financial derivatives such as "event contracts."This request for comments is seen as a further proactive exploration by the SEC regarding the boundaries of ETF regulation. Particularly against the backdrop of sustained growth in demand for crypto ETFs, on-chain asset exposure products, and structured derivatives, regulators are attempting to find a new balance between innovation and risk control. (The Block)